Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer

BACKGROUND: Limited data describe patient-reported outcomes (PROs) of localised oesophageal cancer treated with definitive chemoradiotherapy(CRT). The phase 2/3 SCOPE-1 trial assessed the effectiveness of CRT±cetuximab. The trial for the first time provided an opportunity to describe PROs from a mul...

Descripción completa

Detalles Bibliográficos
Autores principales: Rees, J, Hurt, C N, Gollins, S, Mukherjee, S, Maughan, T, Falk, S J, Staffurth, J, Ray, R, Bashir, N, Geh, J I, Cunningham, D, Roy, R, Bridgewater, J, Griffiths, G, Nixon, L S, Blazeby, J M, Crosby, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647690/
https://www.ncbi.nlm.nih.gov/pubmed/26203761
http://dx.doi.org/10.1038/bjc.2015.258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647690/
https://www.ncbi.nlm.nih.gov/pubmed/26203761
http://dx.doi.org/10.1038/bjc.2015.258

Ejemplares similares